BASF SE (BAS)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:BASF SE (BAS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012256
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BASF SE (BASF) is a chemical company, which carries out research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additives, electronic chemicals, concrete admixtures, pigments, paints, food additives, fungicides, and herbicides. BASF also focuses on exploration and production in oil and gas-rich regions in Europe, North Africa, Russia, South America and the Middle East. The company caters to a wide range of industries including construction, furniture and wood, agriculture, paper and pulp, electronics and electrical, paints and coatings, automotive, home care, nutrition, chemicals and others. BASF carries out R&D in alliance with global customers, scientists and partners. The company operates through a network of manufacturing facilities across the world. It has presence in Europe, Asia Pacific, South America, Africa, the Middle East and North America. BASF is headquartered in Ludwigshafen, Germany.

BASF SE (BAS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BASF SE, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BASF SE, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BASF SE, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BASF SE, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BASF SE, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
BASF SE, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Allylix Raises US$18.2 Million In Series D Financing 10
Partnerships 11
Pion Partners with BASF 11
Catalent Pharma Solutions Enters Into Agreement With BASF 12
Quick-Med Enters Into Distribution Agreement With BASF For MultiStat 13
BASF Enters Into Distribution Agreement With Sigma-Aldrich 14
Licensing Agreements 15
BASF Enters Into Licensing Agreement With Dyadic International For C1 Technology 15
Acquisition 16
Merck And BASF Acquire Majority Stake In Innovation Lab 16
BASF Completes Acquisition Of Pronova BioPharma 17
Basf Acquires Equateq, Manufacturer Of Omega-3 Fatty Acids 19
Sciessent Acquires Agion Technologies 20
BASF SE – Key Competitors 21
BASF SE – Key Employees 22
BASF SE – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
BASF SE, Pharmaceuticals & Healthcare, Key Facts, 2016 2
BASF SE, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BASF SE, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BASF SE, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BASF SE, Deals By Therapy Area, 2011 to YTD 2017 8
BASF SE, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Allylix Raises US$18.2 Million In Series D Financing 10
Pion Partners with BASF 11
Catalent Pharma Solutions Enters Into Agreement With BASF 12
Quick-Med Enters Into Distribution Agreement With BASF For MultiStat 13
BASF Enters Into Distribution Agreement With Sigma-Aldrich 14
BASF Enters Into Licensing Agreement With Dyadic International For C1 Technology 15
Merck And BASF Acquire Majority Stake In Innovation Lab 16
BASF Completes Acquisition Of Pronova BioPharma 17
Basf Acquires Equateq, Manufacturer Of Omega-3 Fatty Acids 19
Sciessent Acquires Agion Technologies 20
BASF SE, Key Competitors 21
BASF SE, Key Employees 22
BASF SE, Subsidiaries 24
BASF SE, Joint Venture 28

★海外企業調査レポート[BASF SE (BAS)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anadolu Hayat Emeklilik A.S.:企業の戦略・SWOT・財務情報
    Anadolu Hayat Emeklilik A.S. - Strategy, SWOT and Corporate Finance Report Summary Anadolu Hayat Emeklilik A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Lee & Man Paper Manufacturing Ltd:企業の戦略・SWOT・財務情報
    Lee & Man Paper Manufacturing Ltd - Strategy, SWOT and Corporate Finance Report Summary Lee & Man Paper Manufacturing Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • AnaMar AB-製薬・医療分野:企業M&A・提携分析
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes that concentrates on the receptors and shows poten …
  • Tulmar Safety Systems Inc.:企業の戦略・SWOT・財務分析
    Tulmar Safety Systems Inc. - Strategy, SWOT and Corporate Finance Report Summary Tulmar Safety Systems Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • LSIS Co Ltd (010120):電力:M&Aディール及び事業提携情報
    Summary LSIS Co Ltd (LSIS) is a provider of power and automation solutions. It manufactures, sells and maintains electronic instruments, copper pipes and automatic machinery. The company provides smart transmission, smart distribution, and smart industrial automation solutions. Under contractual agr …
  • Fujicco Co Ltd:企業の戦略・SWOT・財務情報
    Fujicco Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Fujicco Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Kuwait Projects Company Holding KSC (KPROJ):企業の財務・戦略的SWOT分析
    Kuwait Projects Company Holding KSC (KPROJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Shv Holdings N.V.:企業の戦略・SWOT・財務分析
    Shv Holdings N.V. - Strategy, SWOT and Corporate Finance Report Summary Shv Holdings N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Alberici Corp:企業の戦略的SWOT分析
    Alberici Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • ZoomMed Inc (ZMD):医療機器:M&Aディール及び事業提携情報
    Summary ZoomMed Inc (ZoomMed) is a technical service provider that offers web solutions for medical sectors. The company’s product includes ZoomMed Network, ZRx Prescriber, PraxisLab, and EvPsych. It builds and operates a clinical information exchange platform between physicians and specialists, pat …
  • Sony Financial Holdings Inc.
    Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ampio Pharmaceuticals Inc (AMPE):企業の財務・戦略的SWOT分析
    Summary Ampio Pharmaceuticals Inc (Ampio) formerly Chay Enterprises Inc, operates as a bio pharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company develops compounds that decrease inflammation by inhibiting specific pro-inflammatory co …
  • Etihad Aviation Group PJSC:企業の戦略・SWOT・財務情報
    Etihad Aviation Group PJSC - Strategy, SWOT and Corporate Finance Report Summary Etihad Aviation Group PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bet Shemesh Engines Holdings (1997) Ltd:企業の戦略・SWOT・財務分析
    Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report Summary Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • S-Oil Corporation Inc (010950):企業の財務・戦略的SWOT分析
    S-Oil Corporation Inc (010950) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Heidelberg Pharma AG (WL6):企業の財務・戦略的SWOT分析
    Heidelberg Pharma AG (WL6) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Horizon Oil Ltd (HZN):石油・ガス:M&Aディール及び事業提携情報
    Summary Horizon Oil Ltd (Horizon) is an oil and gas exploration and production company that acquires, explores, develops and produces oil and petroleum properties. The company holds interests in Maari and Manaia fields located in the Taranaki Basin approximately 80 kilometre offshore the north islan …
  • LG Chem Ltd (051910):企業の財務・戦略的SWOT分析
    LG Chem Ltd (051910) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • PharmaCell BV-製薬・医療分野:企業M&A・提携分析
    Summary PharmaCell BV (PharmaCell) is a contract manufacturing organization that offers services for cellular therapies and regenerative medicine. The organization manufactures commercial cell therapy products in the European markets. Its services include cell culture scale-up, manufacturing of adva …
  • YTL Power International Berhad:発電所・企業SWOT分析
    YTL Power International Berhad – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆